Your browser doesn't support javascript.
loading
BNT162b2 Booster Vaccination Elicits Cross-Reactive Immunity Against SARS-CoV-2 Variants B.1.1.529 and B.1.617.2 in Convalescents of All Ages.
Jahrsdörfer, Bernd; Proffen, Matthias; Scholz, Judith; Hägele, Janina; Ludwig, Carolin; Vieweg, Christiane; Grempels, Aline; Fabricius, Dorit; Lotfi, Ramin; Körper, Sixten; Adler, Guido; Schrezenmeier, Hubert.
Affiliation
  • Jahrsdörfer B; Department of Transfusion Medicine, Ulm University, Ulm, Germany.
  • Proffen M; Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service Baden-Württemberg - Hessen and University Hospital Ulm, Ulm, Germany.
  • Scholz J; Department of Transfusion Medicine, Ulm University, Ulm, Germany.
  • Hägele J; Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service Baden-Württemberg - Hessen and University Hospital Ulm, Ulm, Germany.
  • Ludwig C; Department of Transfusion Medicine, Ulm University, Ulm, Germany.
  • Vieweg C; Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service Baden-Württemberg - Hessen and University Hospital Ulm, Ulm, Germany.
  • Grempels A; Department of Transfusion Medicine, Ulm University, Ulm, Germany.
  • Fabricius D; Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service Baden-Württemberg - Hessen and University Hospital Ulm, Ulm, Germany.
  • Lotfi R; Department of Transfusion Medicine, Ulm University, Ulm, Germany.
  • Körper S; Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service Baden-Württemberg - Hessen and University Hospital Ulm, Ulm, Germany.
  • Adler G; Department of Transfusion Medicine, Ulm University, Ulm, Germany.
  • Schrezenmeier H; Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service Baden-Württemberg - Hessen and University Hospital Ulm, Ulm, Germany.
Front Immunol ; 13: 920210, 2022.
Article in En | MEDLINE | ID: mdl-35795665

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viral Vaccines / COVID-19 Type of study: Observational_studies Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: Alemania

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viral Vaccines / COVID-19 Type of study: Observational_studies Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: Alemania